Your Trusted Brand for Over 35 Years

Hangover Prevention References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Wiese JG, Shlipak MG, Browner WS. The alcohol hangover. Ann. Intern. Med. 2000 Jun 6; 132(11): 897-902.
  2. Sprince H, Parker CM, Smith GG, Gonzales LJ. Protective action of ascorbic acid and sulfur compounds against acetaldehyde toxicity: implications in alcoholism and smoking. Agents Actions. 1975 May;5(2):164-73.
  3. Hell D, Six P, Salkeld R. Vitamin B1 deficiency in chronic alcoholics and its clinical correlation. Schweiz. Med. Wochenschr. 1976 Oct 23;106(43):1466-70.
  4. Loguercio C, Taranto D, Beneduce F, del Vecchio Blanco C, de Vincentiis A, Nardi G, Romano M. Glutathione prevents ethanol induced gastric mucosal damage and depletion of sulfhydryl compounds in humans. Gut 1993 Feb; 34(2): 161-5.
  5. Van Zandwijk N. N-Acetylcysteine for lung cancer prevention. Nico Chest 1995 May; 107(5):1437-41.
  6. Marotta F, Safran P, Tajiri H, Princess G, Anzulovic H, Ideo GM, Rouge A, Seal MG, Ideo G. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant. Hepatogastroenterology 2001 Mar-Apr; 48(38): 511-7.
  7. Hancock RD, Viola R. Improving the nutritional value of crops through enhancement of L-ascorbic acid (vitamin C) content: rationale and biotechnological opportunities. J Agric Food Chem. 2005 Jun 29;53(13):5248-57.
  8. Masalkar PD, Abhang SA. Oxidative stress and antioxidant status in patients with alcoholic liver disease.ClinChimActa. 2005 May;355(1-2):61-5.
  9. Zhou JF, Chen P. Studies on the oxidative stress in alcohol abusers in China. Biomed Environ Sci. 2001 Sep;14(3):180-8.
  10. Devasagayam TP, Tilak JC, Boloor KK, et al. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004 Oct;52:794-804.
  11. Martin PR, Singleton CK, Hiller-Sturmhofel S.The role of thiamine deficiency in alcoholic brain disease.Alcohol Res Health. 2003;27(2):134-42.
  12. Betrosian AP, Thireos E, Toutouzas K, et al. Occidental beriberi and sudden death. Am J Med Sci. 2004 May;327(5):250-2.
  13. Maschke M, Weber J, Bonnet U, et al. Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI. J Neurol. 2005 Jun;252(6):704-11.
  14. Perez-Severiano F, Rodriguez-Perez M, Pedraza-Chaverri J, et al. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem Int. 2004 Dec;45(8):1175-83.
  15. Maldonado PD, Barrera D, Rivero I, et al. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free RadicBiol Med. 2003 Aug 1;35(3):317-24.
  16. Prakash S, Joshi YK. Assessment of micronutrient antioxidants, total antioxidant capacity and lipid peroxidation levels in liver cirrhosis. Asia Pac J ClinNutr. 2004;13(Suppl):S110.
  17. Gutteridge JM. The membrane effects of vitamin E, cholesterol and their acetates on peroxidative susceptibility. Res CommunChemPatholPharmacol. 1978 Dec;22(3):563-72.
  18. Waluga M, Hartleb M. Alcoholic liver disease. WiadLek. 2003;56(1-2):61-70.
  19. Mansouri A, Demeilliers C, Amsellen S, Pessayre D, Fromenty B. Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J PharmacolExpTher. 2001 Aug;298(2):737-43.
  20. Ferguson LR, Karunasinghe N, Philpott M. Epigenetic events and protection from colon cancer in New Zealand. Environ Mol Mutagen. 2004a;44(1):36-43.
  21. DeySarkar P, Ramprasad N, DeySarkar I, Shivaprakash TM. Study of oxidative stress and trace element levels in patients with alcoholic and non-alcoholic coronary artery disease.Indian J PhysiolPharmacol. 2007 Apr-Jun;51(2):141-6.
  22. Sakoda LC, Graubard BI, Evans AA, et al. Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer. 2005 Jul 1;115(4):618-24.
  23. McKillop IH, Schrum LW. Alcohol and liver cancer.Alcohol. 2005 Apr;35(3):195-203.
  24. Pascale R, Daino L, Garcea R, et al. Inhibition by ethanol of rat liver plasma membrane (Na+,K+)ATPase: protective effect of S-adenosyl-L-methionine, L-methionine, and N-acetylcysteine. ToxicolApplPharmacol. 1989 Feb;97(2):216-29.
  25. Novitskiy G, Traore K, Wang L, Trush MA, Mezey E. Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol ClinExp Res. 2006 Aug;30(8):1429-35.
  26. Vasdev S, Mian T, Longerich L, Prabhakaran V, Parai S. N-acetyl cysteine attenuates ethanol induced hypertension in rats. Artery. 1995;21(6):312-6.
  27. Egner PA, Munoz A, Kensler TW. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res. 2003 Feb-Mar;523-524:209-16.
  28. Egner PA, Wang JB, Zhu YR, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. ProcNatlAcadSci U S A. 2001 Dec 4;98(25):14601-6.
  29. Kensler TW, Egner PA, Wang JB, et al. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.Gastroenterology. 2004 Nov;127(5 Suppl 1):S310-8.
  30. Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology. 2004b May 20;198(1-3):147-59.Fahey JW, Stephenson KK, Dinkova-Kostova AT, Egner PA, Kensler TW, Talalay P. Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes. Carcinogenesis. 2005 Jul;26(7):1247-55.
  31. Yun CH, Son CG, Chung DK, Han SH. Chlorophyllin attenuates IFN-gamma expression in lipopolysaccharide-stimulated murine splenic mononuclear cells via suppressing IL-12 production. IntImmunopharmacol. 2005 Dec;5(13-14):1926-35.
  32. Simonetti P, Ciappellano S, Gardana C, Bramati L, Pietta P. Procyanidins from Vitisvinifera seeds: in vivo effects on oxidative stress. J Agric Food Chem. 2002 Oct 9;50(21):6217-21.
  33. Fan P, Lou H. Effects of polyphenols from grape seeds on oxidative damage to cellular DNA.Mol Cell Biochem. 2004 Dec;267(1-2):67-74.
  34. Llopiz N, Puiggros F, Cespedes E, et al. Antigenotoxic effect of grape seed procyanidin extract in Fao cells submitted to oxidative stress. J Agric Food Chem. 2004 Mar 10;52(5):1083-7.
  35. Lu Y, Zhao WZ, Chang Z, Chen WX, Li L. Procyanidins from grape seeds protect against phorbol ester-induced oxidative cellular and genotoxic damage. ActaPharmacol Sin. 2004 Aug;25(8):1083-9.
  36. Busserolles J, Gueux E, Balasinska B, et al. In vivo antioxidant activity of procyanidin-rich extracts from grape seed and pine (Pinusmaritima) bark in rats. Int J VitamNutr Res. 2006 Jan;76(1):22-7.
  37. El-Ashmawy IM, Saleh A, Salama OM. Effects of marjoram volatile oil and grape seed extract on ethanol toxicity in male rats.Basic ClinPharmacolToxicol. 2007 Nov;101(5):320-7.
  38. Guo L, Wang LH, Sun B, et al. Direct in vivo evidence of protective effects of grape seed procyanidin fractions and other antioxidants against ethanol-induced oxidative DNA damage in mouse brain cells. J Agric Food Chem. 2007 Jul 11;55(14):5881-91.
  39. Sano A, Yamakoshi J, Tokutake S, Tobe K, Kubota Y, Kikuchi M. Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. BiosciBiotechnolBiochem. 2003 May;67(5):1140-3.
  40. Ward NC, Croft KD, Puddey IB, Hodgson JM. Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic Acid, an important metabolite of proanthocyanidins in humans. J Agric Food Chem. 2004 Aug 25;52(17):5545-9.
  41. Vuong QV, Stathopoulos CE, Golding JB, Nguyen MH, Roach PD. Optimum conditions for the water extraction of L-theanine from green tea. J Sep Sci. 2011 Sept;34(18):2468-74.
  42. Nathan PJ, Lu K, Gray M, Oliver C. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother. 2006;6(2):21-30.
  43. Sadzuka Y, Inoue C, Hirooka S, et al. Effects of theanine on alcohol metabolism and hepatic toxicity.Biol Pharm Bull. 2005 Sep;28(9):1702-6.
  44. Holguin F, Moss I, Brown LA, Guidot DM. Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J Clin Invest. 1998 Feb 15;101(4):761-8.
  45. Powell CL, Bradford BU, Craig CP, et al. Mechanism for prevention of alcohol-induced liver injury by dietary methyl donors. Toxicol Sci. 2010 May;115(1):131-9.
  46. Mato JM, Alvarez L, Corrales F, Pajares MA. S-adenosylmethionine and the liver. In The Liver: Biology and Pathobiology 1994, pp.461-70. Arias IM, Boyer JL, Fausto N, Jakoby WB, Schaachter DA., Eds. New York: Raven Press.
  47. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv. Pharmacol. 1997; 38: 601-28.
  48. Lieber CS. Alcohol: its metabolism and interaction with nutrients. Annu. Rev. Nutr. 2000a; 20: 395-430.
  49. Lieber CS. Hepatic, metabolic, and nutritional disorders of alcoholism: from pathogenesis to therapy. Crit. Rev. Clin. Lab. Sci. 2000b Dec; 37(6): 551-84.
  50. Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J. Hepatol. 2000c; 32(Suppl. 1): 113-28.
  51. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am. J. Gastroenterol. 1999 Jan; 94(1): 200-7.
  52. Thomson, A.D., Pratt, O.E., Jeyasingham, M., Shaw, G.K. Alcohol and brain damage. Hum. Toxicol. 1988 Sep; 7(5): 455-63.
  53. Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol. 2010 Dec 28;16(48):6035-43.
  54. Feher J, Lengyel G. Silymarin in the treatment of chronic liver diseases: past and future. OrvHetil. 2008 Dec 21;149(51):2413-8.
  55. Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett. 2010 May 1;291(1):120-9.
  56. Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybummarianum) for the therapy of liver disease. Am. J. Gastroenterol. 1998 Feb; 93(2): 139-43.
  57. Saller R, Brignoli R, Melzer J, Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin.ForschKomplementmed. 2008 Feb;15(1):9-20.
  58. Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989;9:105-13.
  59. Rajkumar V, Guha G, Kumar RA. Antioxidant and anti-neoplastic activities of Picrorhizakurroa extracts. Food ChemToxicol. 2011 Feb;49(2):363-9.
  60. Rastogi R, Saksena S, Garg NK, Kapoor NK, Agarwal DP, Dhawan BN. Picroliv protects against alcohol-induced chronic hepatotoxicity in rats. Planta Med. 1996 Jun;62(3):283-5.
  61. Saraswat B, Visen PK, Patnaik GK, Dhawan BN. Ex vivo and in vivo investigations of picroliv from Picrorhizakurroa in an alcohol intoxication model in rats. J Ethnopharmacol. 1999 Sep;66(3):263-9.
  62. Rajeshkumar NV, Kuttan R. Inhibition of N-nitrosodiethylamine-induced hepatocarcinogenesis by Picroliv. J ExpClin Cancer Res. 2000 Dec;19(4):459-65.
  63. Rajeshkumar NV, Kuttan R. Protective effect of Picroliv, the active constituent of Picrorhizakurroa, against chemical carcinogenesis in mice. TeratogCarcinog Mutagen. 2001;21(4):303-13.
  64. Aleynik MK, Leo MA, Aleynik SI, Lieber CS. Polyenylphosphatidylcholine opposes the increase of cytochrome P-4502E1 by ethanol and corrects its iron-induced decrease. Alcohol Clin. Exp. Res. 1999 Jan; 23(1): 96-100.
  65. Anand BS, Romero JJ, Sanduja SK, Lichtenberger LM. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am. J. Gastroenterol. 1999 Jul; 94(7): 1818-22.
  66. Aleynik SI, Lieber CS. Polyenylphos-phatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring s-adenosylmethionine. Alcohol. 2003 May;38(3):208-12.
  67. Navder KP, Baraona E, Lieber CS. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J Nutr. 1997 Sep;127(9):1800-6.
  68. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol ClinExp Res. 2003 Nov;27(11):1765-72.